Enrolling 42% of Total Participants Across 49 States for an Oncology Trial

Science 37 was the top enrolling site, delivering 42% of total study enrollment and outperforming the other 100 traditional sites. Enrolling patients across 49 states, Science 37 achieved 24% minority representation and exceeded its contracted goal with over 12,000 participants (original goal: 7,000), accelerating the study timeline by over 3 years.